Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.
Vesicular stomatitis virus (VSV) has recently gained attention for its oncolytic ability in cancer treatment. Initially, we hypothesized that VSV infection could increase immune recognition of cancer cells through induction of the immune stimulatory NKG2D-ligands. Here we show that VSV infection lea...
Guardado en:
Autores principales: | Helle Jensen, Lars Andresen, Jens Nielsen, Jan Pravsgaard Christensen, Søren Skov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2713a62b59c74d7881c0a44827aae6a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structure of the vesicular stomatitis virus N⁰-P complex.
por: Cédric Leyrat, et al.
Publicado: (2011) -
Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments
por: Bianca S. Heinrich, et al.
Publicado: (2018) -
NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Di Yang, et al.
Publicado: (2017) -
Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice
por: Sarah Hulsey Stubbs, et al.
Publicado: (2021) -
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
por: Sergio E. Rodriguez, et al.
Publicado: (2019)